Xiao et al., who used a mouse model and conducted chemo-proteomic analysis of cardiac lysates, found that C-terminal Src kinase (CSK) was the most likely target for ibrutinib-induced AF (40). This evidence concerns the gene CSK and atrial fibrillation.